Additionally, results for other drug sensitivity markers (ABCG2, ABCB1, BCL2; P < 0.00001) and cancer stem cells (CSCs) markers (ALDH1A1, PROM1; P < 0.01) were also presented (Fig. S1E-I). Here, BCL2 is linked to cancer.